Metraipolis › archive › dc_b153ab45da26
Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French… — Europe PMC PMID:42567006
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42567006
- DOI
- 10.1016/j.esmoop.2026.108324
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T18:02:28.562Z
- SHA-256 of the archived text
5d3215aa4ab0b4a3c3dda3b2840324fbf90edb1ec7e46e718da7bdf07d0c7738- Stable URL of this page
https://metraipolis.com/documento/dc_b153ab45da26
How to cite
Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French… — Europe PMC PMID:42567006 — Europe PMC (en), https://europepmc.org/article/MED/42567006 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b153ab45da26 (Metraipolis archive dc_b153ab45da26, sha256 5d3215aa4ab0b4a3c3dda3b2840324fbf90edb1ec7e46e718da7bdf07d0c7738)
BibTeX
@misc{dcb153ab45da26,
title = {Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French… — Europe PMC PMID:42567006},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42567006},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b153ab45da26; sha256 5d3215aa4ab0b4a3c3dda3b2840324fbf90edb1ec7e46e718da7bdf07d0c7738},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42567006. Agents can read the archived copy with the MCP tool read_document.